Micaela Crowley
Optometrist · Westminster, MANPI 1891248084
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $56,248 of the $87,762 with a category attached, or 64.1%. Coopervision Inc. accounts for 60.2% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2024 at $24,118 and has fallen 97.4% since, to $631 in 2025. Among optometrist clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 175 payments — averaging $501.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopervision Inc.$53K
- Oyster Point Pharma, Inc.$26K
- Kala Pharmaceuticals, Inc.$5K
- Novartis$2K
- Shire North American Group Inc$949
- Carl Zeiss Meditec USA, Inc.$491
- plus $608 from 8 others
Across 1 payment — averaging $7275.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$7K
What the payments were for
- Consulting fees$10,58812%
- Speaking & faculty fees$56,24864%
- Travel & lodging$17,02119%
- Food & beverage$3,9064%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coopervision Inc. | 82 | $52,861 |
| Oyster Point Pharma, Inc. | 56 | $26,175 |
| Kala Pharmaceuticals, Inc. | 10 | $5,140 |
| Novartis | 4 | $1,538 |
| Shire North American Group Inc | 4 | $949 |
| Carl Zeiss Meditec USA, Inc. | 8 | $491 |
| Sight Sciences, Inc. | 4 | $156 |
| Glaukos Corporation | 1 | $140 |
| Tarsus Pharmaceuticals, Inc. | 1 | $122 |
| Dompe US, Inc. | 1 | $118 |
| Carl Zeiss Meditec, Inc. | 1 | $20 |
| Sun Pharmaceutical Industries Inc. | 1 | $18 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $17 |
| Alcon | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MyDay Contact Lens$26,313
- TYRVAYA$24,819
- Multiple Brands Contact Lens$14,053
- EYSUVIS$5,069
- Non-Product Brand Specific$4,049
- XIIDRA$2,440
- Onefit Contact Lens$2,250
- CIRRUS HD-OCT$413
- INVELTYS$300
- Clariti Contact Lens$158
- Photrexa Viscous and Photrexa$140
- XDEMVY$122
- Oxervate$118
How this compares
$87,762 in reported general payments places this provider in the 95th percentile of 1,084 optometrist providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XiidraLifitegrast | 36 | $53,069 |
| RestasisCyclosporine | 19 | $35,414 |
| Restasis MultidoseCyclosporine | 18 | $18,974 |
| ErythromycinErythromycin Base | 11 | $129 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Westminster
- Donald KorbBoston$373K
- Jaclyn GarlichBoston$162K
- Jessica CrookerScituate$99K
- Kristen BrownBoston$87K
- Timothy BossieBoston$75K
- Sabrina GaanMedfield$66K
- Blair O'ReillyDedham$43K
- John MagalhaesN Dartmouth$40K
- Anita GulmiriBrookline$28K
- Lawerence BaitchWorcester$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.